Li Yanlin, Wang Guoliang, Cao Bin, Gao Gang, Ma Ke, Chen Wendong, Xu Peng, Yang Guang
Department of Sports Medicine, the First Hospital Affiliated to Kunming Medical University, Kunming Yunnan, 650000, P.R.China.
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2012 Jun;26(6):652-6.
To investigate the influence on matrix metalloproteinases (MMP) 3, 9, and 13 levels of human articular cartilage cells after blocking stromal cell derived factor 1 (SDF-1)/chemokine receptor 4 (CXCR4) signaling pathway with AMD3100 and to define the function mechanism of AMD3100.
A total of 144 cartilage blocks from 12 osteoarthritis (OA) patients undergoing total knee arthroplasty (OA cartilage group) and 144 normal cartilage blocks (Mankin score of 0 or 1) from 12 patients undergoing traumatic amputation (normal cartilage group). OA cartilage group was further divided into subgroups A1, B1, and C1, and normal cartilage group into subgroups A2, B2, and C2. The cartilage tissues were cultured in DMEM solution containing 100 ng/mL SDF-1 and 1 000 nmol/L AMD3100 in subgroup A, 100 ng/mL SDF-1 and 1 000 nmol/L MAB310 in subgroup B, and 100 ng/mL SDF-1 in subgroup C, respectively. The levels of MMP-3, 9, and 13 were measured by ELISA; the expressions of MMP-3, 9, and 13mRNA were tested by RT-PCR.
ELISA and RT-PCR results showed that the levels of MMP-3, 9, and 13 and the expressions of MMP-3, 9, and 13 mRNA were significantly lower in subgroup A than in subgroups B and C at the same time points (P < 0.05); the levels of MMP-3, 9, and 13 and the expressions of MMP-3, 9, and 13 mRNA were significantly higher in OA cartilage group than in normal cartilage group at the same time points (P < 0.05).
SDF-1 could induce overexpression and release of MMP-3, 9, and 13 in the articular cartilage through the SDF-1/CXCR4 signaling pathway; AMD3100 could reduce the mRNA expressions and secretion of MMP-3, 9, and 13 in OA cartilage by blocking the SDF-1/CXCR4 signaling pathway; but AMD3100 could not make the secretion of MMP-3, 9, and 13 return to normal levels in OA cartilage.
探讨用AMD3100阻断基质细胞衍生因子1(SDF-1)/趋化因子受体4(CXCR4)信号通路后对人关节软骨细胞基质金属蛋白酶(MMP)3、9和13水平的影响,并明确AMD3100的作用机制。
选取12例行全膝关节置换术的骨关节炎(OA)患者的144块软骨块(OA软骨组)和12例行创伤性截肢患者的144块正常软骨块(Mankin评分为0或1)(正常软骨组)。OA软骨组进一步分为A1、B1和C1亚组,正常软骨组分为A2、B2和C2亚组。软骨组织分别在含100 ng/mL SDF-1和1 000 nmol/L AMD3100的DMEM溶液中培养(A亚组)、含100 ng/mL SDF-1和1 000 nmol/L MAB310的DMEM溶液中培养(B亚组)、含100 ng/mL SDF-1的DMEM溶液中培养(C亚组)。采用酶联免疫吸附测定(ELISA)法检测MMP-3、9和13水平;采用逆转录-聚合酶链反应(RT-PCR)法检测MMP-3、9和13mRNA的表达。
ELISA和RT-PCR结果显示,同一时间点A亚组MMP-3、9和13水平及MMP-3、9和13mRNA表达均显著低于B、C亚组(P<0.05);同一时间点OA软骨组MMP-3、9和13水平及MMP-3、9和13mRNA表达均显著高于正常软骨组(P<0.05)。
SDF-1可通过SDF-1/CXCR4信号通路诱导关节软骨中MMP-3、9和13的过表达及释放;AMD3100可通过阻断SDF-1/CXCR4信号通路降低OA软骨中MMP-3、9和13的mRNA表达及分泌;但AMD3100不能使OA软骨中MMP-3、9和13的分泌恢复至正常水平。